| Phase 14 trials |
|
Phase 1
|
NCT07559240 |
May → Jun 2026 overdue |
obesity disorder |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT07502001 |
Apr → Dec 2026 expected |
obesity disorder |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT06637020 |
Jun → Dec 2024 |
morbid obesity |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT06640647 |
Mar → Aug 2024 |
obesity disorder |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
Completed
|
No outcome recorded
|
| Phase 23 trials |
|
Phase 2
|
NCT07521631 |
Mar 2026 → Feb 2027 expected |
obesity disorder |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07109700 |
Apr 2025 → Jan 2026 overdue |
type 2 diabetes mellitus |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06886126 |
Feb → Sep 2025 overdue |
obesity disorder |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
Recruiting
|
No outcome recorded
|
| Phase 33 trials |
|
Phase 3
|
NCT07417306 |
Mar 2026 → Aug 2027 expected |
type 2 diabetes mellitus |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT07394114 |
Feb 2026 → Aug 2027 expected |
type 2 diabetes mellitus |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT07279194 |
Oct 2025 → Sep 2026 expected |
obesity disorder |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
Recruiting
|
No outcome recorded
|